Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
D2.100 - The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors
D2.111 - Wheeze phenotypes in infants whose mothers have asthma
D2.99 - A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis
D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma
D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity
D2.104 - Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma
D2.105 - Clinical remission of severe asthma: 5-year follow-up
D2.106 - Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness
D2.107 - Effect of n-3 long-chain polyunsaturated fatty acid and vitamin D supplementation on human lung organoids
D2.108 - Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain
D2.109 - Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download